Skip to content

    ABEONA THERAPEUTICS (ABEO) stock price & financials

    View ABEO earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance14.2% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $400.0K
    $8.72M
    $11.38M
    +2745.0%
    Strengthening
    Operating Profit
    -$15.35M
    -$16.67M
    -$19.73M
    -$22.79M
    -$24.02M
    -56.5%
    -$22.91M
    -37.4%
    -$23.03M
    -16.8%
    -$13.65M
    +40.1%
    Weakening
    Net Profit
    -$30.27M
    -$9.29M
    -$12.03M
    $108.83M
    -$5.16M
    +82.9%
    -$20.46M
    -120.2%
    -$17.07M
    -41.9%
    -$20.19M
    -118.6%
    Weakening
    EPS
    $-0.63
    $-0.24
    $2.07
    $-0.10
    +84.1%
    $-0.30
    -25.0%
    $-0.35
    -116.9%
    Weakening
    Other Income
    $145.0K
    $663.0K
    $141.0K
    $89.0K
    $129.0K
    -11.0%
    $51.0K
    -92.3%
    $50.0K
    -64.5%
    -$6.0K
    -106.7%
    Weakening
    Interest
    $1.10M
    $1.08M
    $998.0K
    $957.0K
    $901.0K
    -18.2%
    $884.0K
    -18.3%
    $830.0K
    -16.8%
    $696.0K
    -27.3%
    Weakening
    Depreciation
    Profit before Tax
    -$30.27M
    -$12.03M
    $124.34M
    -$20.36M
    +32.7%
    -$20.68M
    -$17.07M
    -41.9%
    -$20.19M
    -116.2%
    Weakening
    MarginsOPM
    -5698.0%
    -264.1%
    -120.0%
    +97.9%
    Strengthening
    Tax
    12.5%
    74.7%
    -0.0%
    Weakening
    ReturnsROIC
    3.9%
    1.2%
    1.5%
    -14.0%
    0.7%
    -82.9%
    2.6%
    +120.2%
    2.2%
    +41.9%
    2.6%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$18.75M$129.26M$12.60M$32.94M$14.22M$14.47M$23.36M$78.44M$56.23M
    Short-Term Investments
    Total Current Assets$88.85M$132.39M$97.74M$56.29M$53.10M$55.74M$100.85M$204.91M$164.58M
    Net PP&E$9.44M$21.20M$18.35M$21.74M$11.07M$7.99M$7.98M$13.88M$14.10M
    Goodwill$32.47M$32.47M$32.47M
    Intangibles$43.04M$36.18M$1.50M$1.38M$0
    Total Assets$174.40M$223.38M$151.20M$79.59M$64.21M$64.00M$108.93M$219.57M$179.51M
    LiabilitiesTotal Current Liabilities$20.35M$38.70M$41.96M$16.62M$7.78M$13.42M$16.59M$29.57M$24.81M
    Short-Term Debt$5.93M$12.22M$13.33M
    Long-Term Debt$13.04M$7.81M$1.66M
    Long-Term Leases$6.25M$5.26M$7.56M$5.85M$4.40M$3.26M$4.07M$3.60M
    Total Liabilities$40.35M$44.95M$48.65M$37.22M$37.45M$49.18M$64.90M$60.35M$51.45M
    EquityCommon Stock & APIC$479.0K$836.0K$961.0K$1.47M$177.0K$265.0K$457.0K$550.0K$572.0K
    Retained Earnings-$410.19M-$486.47M-$570.70M-$655.64M-$695.34M-$749.52M-$813.26M-$742.08M-$779.34M
    Total Equity$134.04M$178.43M$102.55M$42.37M$26.76M$14.83M$44.03M$159.22M$128.06M
    HighlightsNet Cash / (Debt)$4.39M$58.40M$41.24M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$39.11M-$62.82M-$35.02M-$65.67M-$43.48M-$37.01M-$56.02M-$76.33M-$76.44M
    Cash from Investing-$85.09M$59.98M-$83.71M$66.06M-$23.96M$208.0K-$39.24M$105.03M-$34.42M
    Cash from Financing$5.48M$113.90M$1.94M$24.86M$43.17M$37.06M$104.14M$26.04M$3.22M
    SummaryCapital Expenditure-$9.24M-$6.31M-$1.34M-$4.15M-$130.0K-$331.0K-$2.45M-$7.97M-$5.09M
    Free Cash Flow-$48.35M-$69.13M-$36.35M-$69.82M-$43.61M-$37.34M-$58.46M-$84.30M-$81.53M
    FCF Margin-1612.9%-363.6%-2327.2%-3084.4%-1066.9%-1448.5%

    Ratios